Process for the preparation of .alpha.-acetolactic acid

The present invention is in the field of food flavorings. The invention relates in particular to a process for the production of .alpha.-acetolactic acid (2-hydroxy-2-methyl-3-oxobutanoic acid) and/or diacetyl (2,3-butanedione).
For many years already, diacetyl has been used as a flavoring additive, e.g. for butter-like products. Since diacetyl is very volatile, it will gradually escape from a flavored food product, thus limiting its direct use as a flavoring substance. Alpha-acetolactic acid (also referred to herein as .alpha.-acetolactate) is a diacetyl precursor which can slowly release diacetyl by oxidative decarboxylation. Therefore .alpha.-acetolactic acid can be used as an indirect flavoring substance having a prolonged flavoring effect. Due to its limited stability, in particular in liquid medium, and due to its difficult preparation resulting in products having a low .alpha.-acetolactic acid content, however, a large-scale use of .alpha.-acetolactic acid for flavoring purposes has not been possible thus far.
A process for the preparation of an aroma composition containing .alpha.-acetolactic acid is known from European Patent application 247.646. According to that process, a pasteurised milk product is fermented with a culture of Streptococcus diacetylactis under conditions which decrease the conversion of .alpha.-acetolactic acid. Typically, a product containing 0.01% to 0.1% of .alpha.-acetolactic acid can be obtained using this known process. An improved process for producing an aroma composition containing over 0.4% of .alpha.-acetolactic acid by fermentation with pretreated lactic acid bacteria is described in European Patent application 91202042.7.
It has been found now that .alpha.-acetolactic acid and/or derivatives thereof can be produced in high yields by using recombinant techniques. Accordingly, the present invention, in its first aspect, relates to a process wherein a recombinant micro-organism containing an .alpha.-acetolactate synthase encoding sequence is incubated in a medium containing an .alpha.-acetolactic acid precursor.
The .alpha.-acetolactate synthase encoding sequence contained in the micro-organism preferably comprises the nucleotide sequence essentially corresponding to the sequence 550-2211 of the appending FIG. 1 (SEQ ID NO: 1). The sequence is preferably incorporated in the genome of the micro-organism, in a single copy or in multiple copies, but it may also be contained e.g. in a plasmid in the micro-organism.
"Essentially corresponding to the sequence" is understood as to include genetic variants, such as hybrid sequences containing an .alpha.-acetolactate synthase encoding sequence coupled to homologous or heterologous regulatory regions, sequences encoding mutant .alpha.-acetolactate synthase proteins, and degenerate sequences. The nucleotide sequence may also be a sequence having mutations, including mutations which still allow hybridization with .alpha.-acetolactate synthase encoding sequences and genetic variants thereof, or which, on expression, still yield a protein with .alpha.-acetolactate synthase activity.
The recombinant micro-organism to be used in the process according to the invention preferably does not exhibit substantial .alpha.-acetolactate decarboxylase activity. This may be achieved by using a micro-organism wherein .alpha.-acetolactate decarboxylase activity is substantially reduced or absent, e.g. by a deletion, an insertion, a substitution or a mutation in its .alpha.-acetolactate decarboxylase encoding region. Substantially reduced activity is to be understood as being less than 50% of the original activity, preferably less than 20%, more preferably less than 10% of the original activity and most preferably no detectable activity.
The .alpha.-acetolactate precursor present in the medium of the process according to the invention may be pyruvic acid, pyruvate, citric acid and/or citrate and/or precursors thereof, such as oxaloacetic acid, lactic acid, lactose etc. It is noted that wherever an organic acid is mentioned in this specification, this shall be understood to comprise both the free acid and the anion and any salts thereof; similarly, where the anion of an organic acid is mentioned, this also covers the acid and any salts. Preferably, the medium wherein .alpha.-acetolactate is produced contains pyruvate and/or citrate.
In a second aspect, the present invention relates to a recombinant vector comprising a nucleotide sequence coding for .alpha.-acetolactate synthase. Another aspect of the invention is concerned with a micro-organism capable of making .alpha.-acetolactate synthase, into which micro-organism a recombinant vector of the latter type has been introduced.
Alpha-acetolactate synthase is an enzyme which catalyses the conversion of pyruvic acid into .alpha.-acetolactic acid.
We have succeeded in isolating a gene coding for .alpha.-acetolactate synthase properties from Lactococcus lactis sp. lactis vat. diacetylactis. We have introduced this gene into vectors, so-called recombinant expression plasmids, which were successfully used to express the gene in micro-organisms.
Accordingly, the present invention is specifically concerned with a recombinant vector comprising a nucleotide sequence coding for an .alpha.-acetolactate synthase, which vector upon transfer into a host micro-organism enables the expression of .alpha.-acetolactate synthase and comprises an amino acid sequence which is essentially identical to the amino acid sequence given in FIG. 1 (SEQ ID NO: 2).
It is noted that the amino acid sequence represented in FIG. 1 can be modified without having a substantial adverse effect on the functionality, i.e. .alpha.-acetolactate synthase activity, of the polypeptide. Also it may be possible to improve the functionality of the polypeptide by introducing modifications into the amino acid sequence. Thus the present invention not only covers recombinant vectors comprising a nucleotide sequence coding for the above amino acid sequence, but also vectors comprising a nucleotide sequence coding for a different amino acid sequence which is still capable of converting pyruvate into .alpha.-acetolactate.
A quantitative measure of the similarity of amino acid sequences of .alpha.-acetolactate synthase enzymes is the percentage similarity calculated by means of the algorithm of Needleman and Wunsch as published in J. Mol. Biol. 48: 443-445 (1970). The percentage similarity can suitably be calculated using a computer programme named "Gap" which forms part of a sequence analysis software package (version 6.0) issued by G.C.G (see also Devereux et al. Nucleic Acids Res. 12: 387-395 (1984)). The percentage similarity between the amino acid sequence encoded by the nucleotide sequence of the vector according to the present invention, and any other unique sequence, as calculated using the algorithm of Needleman and Wunsch, generally exceeds 60%. More preferably this percentage similarity exceeds 75%, still more preferably 85%, and most preferably it exceeds 90%.
The gene coding for .alpha.-acetolactate synthase can suitably be cloned in a host micro-organism, using the present recombinant vector, thereby transforming the host micro-organism and/or its progeny to express the gene, resulting in the production of an enzyme having .alpha.-acetolactate synthase properties, optionally after further treatment of the protein produced. The present recombinant vector can be used to transform micro-organisms previously unable to make .alpha.-acetolactate into .alpha.-acetolactate producing micro-organisms. Alternatively said vector may be used to increase the .alpha.-acetolactate synthase activity of micro-organisms already capable of making .alpha.-acetolactate. When expression of the present gene in a micro-organism has been effected, said micro-organism can normally be reproduced using conventional fermentation techniques.
Whenever reference is made herein to the .alpha.-acetolactate synthase activity of an enzyme, what is meant is that said enzyme catalyses the formation of .alpha.-acetolactate in a pyruvate-containing .alpha.-acetolactate-free aqueous system. By catalysis is meant here that the formation of .alpha.-acetolactate is not observed in the absence of the enzyme and that the enzyme is not changed during the process.
It is noted that under processing conditions the .alpha.-acetolactate formed may be converted into diacetyl through oxidative decarboxylation. In order to arrive at the desired level of .alpha.-acetolactate activity, it is advisable to also monitor the amount of diacetyl and acetoin formed. Known analytical methods, such as .sup.13 C NMR techniques, can be used for monitoring the production of .alpha.-acetolactate and diacetyl.
It is known that more than one codon may encode the same amino acid. Thus, generally there exist numerous nucleotide sequences coding for the same polypeptide. It will be appreciated by a skilled person that it is advantageous to adapt the codons of a heterologous gene in the preferred codon usage of the host cell. The nucleotide sequence of the gene encoding .alpha.-acetolactate synthase as obtained from Lactococcus lactis sp. lactis vat. diacetylactis is represented in FIG. 1 (SEQ ID NO: 1). It should be noted that slight deviations from the nucleotide sequence, even when affecting the amino acid sequence of the enzyme encoded therein, will not necessarily effect the functionality of said enzyme.
In addition to the nucleotide sequence coding for .alpha.-acetolactate synthase, the present recombinant vector comprises nucleotide sequences which enable the expression of the recombinant vector in host micro-organisms. Generally the present recombinant vector comprises:
(a) a double-stranded DNA (ds-DNA) coding for .alpha.-acetolactate synthase starting with a translational initiation codon, bound to the 5'-end of the coding region of the plus strand of the ds-DNA;
(b) an expression regulon situated upstream of the plus strand of the ds-DNA;
(c) a translational stop codon, bound to the 3'-end of the coding region of the plus strand of the ds-DNA, optionally followed by:
(d) a transcription termination sequence.
The present recombinant vector can suitably be introduced into bacteria or yeast in the form of a plasmid, i.e. an autonomously replicating, generally circular minichromosome. Alternatively the present recombinant vector can be integrated into the chromosomal DNA of bacteria, mould or yeast. The integration of the nucleotide sequence coding for .alpha.-acetolactate synthase into the chromosomal DNA offers the advantage that the transformed micro-organism will produce a progeny which is equally capable of forming .alpha.-acetolactate synthase.
In order to effect the integration of the nucleotide sequence coding for .alpha.-acetolactate synthase into the chromosomal DNA of a micro-organism, it is advantageous to additionally include in the present recombinant vector one or more nucleotide sequences which facilitate the integration of the gene coding for .alpha.-acetolactate synthase.
According to yet another preferred embodiment the present vector comprises (e) at least one DNA sequence derived from a food-grade organism coding for at least one enzyme that gives the transformed host micro-organism a selection advantage. Suitable examples are DNA sequences coding for enzymes involved in carbohydrate metabolism, more particularly in the metabolism of sugars such as lactose, sucrose and raffinose, e.g. phospho-.beta.-galactosidase and .alpha.-galactosidase. Such DNA sequences are preferably obtained from food-grade organisms, in particular food-grade micro-organisms.
The present invention also encompasses a recombinant vector comprising a nucleotide sequence promoting .alpha.-acetolactate gene expression. In particular, this nucleotide sequence essentially corresponds to the sequence 1-549, in particular to the sequence 178-549 of FIG. 1 (SEQ ID NO: 1), or a part thereof. This vector may further contain a nucleotide sequence which encodes other valuable proteins, such as enzymes essential for metabolizing oligosaccharides, or which encodes proteases or peptidases or their maturases, or which encodes a food-grade natural bacteriocidal agent and/or immune proteins for such an agent and/or proteins involved in the proper secretion of such an agent.
Another aspect of the present invention relates to a micro-organism capable of producing .alpha.-acetolactate synthase, wherein the micro-organism is selected from the group consisting of a host micro-organism in which a recombinant vector as hereinbefore defined has been introduced and the progeny obtained from such a host micro-organism. The micro-organisms encompassed by the present invention include bacteria, moulds, yeasts etc. According to a preferred embodiment of the invention, the present micro-organism is a bacterium, more preferably said micro-organism is a food-grade bacterium. Most preferably the present micro-organism is selected from of genera Lactococcus, Streptococcus, Lactobacillus, Leuconostoc, Pediococcus, Bacillus, Bifidobacterium, Brevibacterium, Micrococcus, Propionibacterium, Staphylococcus, Streptococcus, Gluconobacter, Acetobacter, Vibrio costicola, Corynebacterium and Zymomonas.
According to a more preferred embodiment of the invention the present micro-organism is selected from the genera Lactococcus, Streptococcus, Lactobacillus, Leuconostoc, Bifidobacterium, Brevibacterium and Propionibacterium.
As a further preferred embodiment, the micro-organism has a substantially reduced .alpha.-acetolactate decarboxylase activity. This is achieved in particular by inactivating the .alpha.-acetolactate decarboxylase gene in the micro-organism, which is preferably selected from the genera Lactococcus, Streptococcus, Lactobacillus, Leuconostoc, Bifidobacterium, Brevibacterium and Propionibacterium.
The present micro-organisms can advantageously be used in the production of .alpha.-acetolactate or derivatives thereof (e.g. diacetyl) by growing said micro-organism under optimum conditions. Conditions which substantially affect the amount of .alpha.-acetolactate/diacetyl produced are temperature, composition of the growth medium and aeration. Generally the growth medium should mainly consist of water and contain a substrate selected from the group consisting of citrate, pyruvate and precursors thereof. Normally the growth medium additionally contains salts, and suitable sources of carbon and nitrogen to enable the micro-organism to grow.
Efficient production of .alpha.-acetolactate can be achieved in particular by (a) growth of the micro-organisms in an optimal medium or (b) reduced growth or even only maintenance of the micro-organisms thereby converting the substrate almost quantitatively into .alpha.-acetolactate.
The present micro-organism may suitably be used in a process for producing .alpha.-acetolactate and/or diacetyl, wherein the latter compounds are separated from the micro-organism, e.g. by centrifugation, ultra-filtration or distillation. Alternatively the complete composition obtained after fermentation with the present micro-organism can be used in for instance foodstuffs, optionally after evaporating the water therefrom. If used in the latter manner, the present micro-organism should be food-grade.

DESCRIPTION OF THE DRAWINGS
FIGS. 1A-1C shows the nucleotide sequence of the L. diacetylactis .alpha.-acetolactate synthase gene together with the deduced amino acid sequence (listed separately as SEQ ID NO: 1 and SEQ ID NO: 2, respectively, in the SEQUENCE LISTING).
FIG. 2 shows the restriction enzyme maps of plasmid pADC1 and its deletion derivatives pADC2, and pADC3.
FIG. 3 shows concentrations of .sup.13 C-labelled pyruvate and its metabolites upon fermentation at 37.degree. C. with E. coli 294.
FIG. 4 shows concentrations of .sup.13 C-labelled pyruvate and its metabolites upon fermentation at 37.degree. C. with E. coli 294(pADC1).
FIG. 5 shows concentrations of .sup.13 C-labelled pyruvate and its metabolites upon fermentation at 37.degree. C. with E. coli 294(pADC2).
FIG. 6 shows concentrations of .sup.13 C-labelled pyruvate and its metabolites upon fermentation at 37.degree. C. with E. coli 294(pADC3).
FIG. 7 shows concentrations of .sup.13 C-labelled pyruvate and its metabolites obtained during incubation with a lysate of B. subtilis (pUR5400).
FIG. 8 shows concentrations of .sup.13 C-labelled pyruvate and its metabolites obtained during incubation with a lysate of B. subtilis.
FIG. 9 shows concentrations of .sup.13 C-labelled pyruvate and its metabolites obtained during incubation with a lysate of L. lactis MG1363.
FIG. 10 shows concentrations of .sup.13 C-labelled pyruvate and its metabolites obtained during incubation with a lysate of L. lactis MG1363(pUR5401).
FIG. 11 shows concentrations of .sup.13 C-labelled pyruvate and its metabolites obtained during incubation with a lysate of L. diacetylactis SD803.
FIG. 12 shows concentrations of .sup.13 C-labelled pyruvate and its metabolites obtained during incubation with a lysate of L. diacetylactis SD803(pUR5402).

The invention is illustrated by means of the following non-limiting examples:
EXAMPLE 1
Cloning and expression of the gene for .alpha.-acetolactate synthase in E. coli.
In order to identify genes involved in acetoin and/or diacetyl formation, a genomic library of Lactococcus lactis subsp. lactis biovar diacetylactis (L. diacetylactis) was constructed in plasmid vector pBR322 (Bolivar et al., Gene 2: 95-113 (1977)) in Escherichia coli. Therefore a preparation of total cell DNA of L. diacetylactis strain DSM20384 was partially digested with the restriction enzyme Sau3A, and subsequently ligated in plasmid pBR322 that was digested to completion with the restriction enzyme BamHI, essentially as has been described by Maniatis et al. (Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 1982). The ligation mix was then used to transform E. coli SF8 cells selecting on LB agar plates supplemented with 100 .mu.g/ml ampicillin.
The Voges-Proskauer (VP) reaction (Krampitz, L. O., Methods Enzymol. 3: 271-283 (1957)) was used to screen E. coli transformants for the formation of acetoin when grown on pyruvate as the sole carbon source. Using this assay wild-type E. coli cells were found to be unable to produce acetoin. Among the more than 600 individual transformant clones carrying various fragments of the L. diacetylactis genome that were screened, one clone gave a positive VP reaction. The recombinant plasmid was isolated from this clone, and further characterized by restriction enzyme analysis (Goelling, D., and Stahl, U., Appl. Environ. Microbiol. 54: 1889-1891 (1988)). A restriction map of the plasmid, designated pADC1, is shown in FIG. 2.
From this positive VP reaction Goelling and Stahl concluded to have cloned the L. diacetylactis gene for .alpha.-acetolactate decarboxylase (.alpha.-ALD) (Goelling, D., and Stahl, U., Appl. Environ. Microbiol. 54: 1889-1891 (1988)). However, acetoin formation from pyruvate is the result of two enzymic activities, i.e. .alpha.-acetolactate synthase (.alpha.-ALS) and .alpha.-ALD. To discriminate whether the production of acetoin by transformant E. coli(pADC1) cells results from .alpha.-ALS activity and/or from .alpha.-ALD activity encoded by the recombinant plasmid, the conversion of 3-.sup.13 C-labelled pyruvate was studied using the .sup.13 C-NMR technique (McGready, V. R. et al., in `Functional studies using NMR`, 1987. Springer, London, UK). Cells of E. coli K12 strain 294 (Backman et al. Proc. Natl. Acad. Sci. USA 73: 4174-4178 (1976)) with or without pADC1 were first cultivated in 10 ml LB broth for 6 hours at 37.degree. C. A 0.9 ml sample was then added to the test mixture which further contained 0.05 ml D.sub.2 O, 0.05 ml 3-.sup.13 C-pyruvate stock solution (Isotec Inc., Miamisburg Ohio 45342, Cat no 83-62024) (to a final concentration of 0.45 mMol). 0.5 ml of this mixture was transferred into a 0.5 cm NMR tube and the NMR spectra were collected overnight (at 90 Mhz on a Bruker AM-360 spectrometer interfaced to an Aspect 3000 computer). The 3-.sup.13 C-pyruvate was used to facilitate the quantification of the reaction products (by .sup.13 C-NMR) and has no special property in the conversion process. No complete conversion of .sup.13 C-pyruvate is obtained with any of the strains under the conditions used. In both cases the formation of acetic acid and lactic acid was observed (FIGS. 3, and 4). However, cells containing pADC1 produced in addition .alpha.-acetolactate and acetoin. The production of .alpha.-acetolactate starts immediately from the start of the experiment, whereas acetoin appears at a much slower rate. Clearly identifiable acetoin signals are obtained only after some 5 hours of incubation. The production of .alpha.-acetolactate in pADC1 containing cells means that these cells contain .alpha.-acetolactate synthase activity. E. coli 294 cells lack this activity, as no .alpha.-acetolactate was produced. It is therefore concluded that the 4.5 kbp DNA insert in pADC1 carries the active gene for .alpha.-ALS, rather than the gene for .alpha.-ALD, as stated by Goelling and Stahl (Goelling, D., and Stahl, U., Appl. Environ. Microbiol. 54: 1889-1891 (1988)). Whether the clone in addition contains the gene for .alpha.-ALD is not clear. Since .alpha.-acetolactate is chemically unstable at pH values lower than 7, the acetoin observed may well be the result of a chemical decarboxylation of .alpha.-acetolactate.
Two deletion derivatives of pADC1 were also tested by .sup.13 C NMR analysis. Plasmid pADC2 was obtained by deletion of an approximately 1.3 kbp HindIII fragment from pADC1, while plasmid pADC3 lacked a 2.5 kbp EcoRV fragment (Goelling, D., and Stahl, U., Appl. Environ. Microbiol. 54: 1889-1891 (1988)) (FIG. 2). As the E. coli(pADC1) cells, plasmid pADC2 containing cells showed production of acetic acid, lactic acid and .alpha.-acetolactate followed by formation of acetoin at a much slower rate (FIG. 5). Cells containing pADC3 only produced acetic acid and lactic acid, just like the host E. coli 294 (FIG. 6). It means, that the gene for .alpha.-ALS must be located after the HindIII site on the 3.0 kbp right half part of the insert (FIG. 2).
EXAMPLE 2
Nucleotide sequence analysis of pADC1
The DNA sequence of part of the 4.5 kbp partial Sau3A DNA fragment, as present on plasmid pADC1, was established by the Sanger dideoxy chain termination procedure (Sanger, F., Nicklen, S., and Coulson, A. R., (1977), Proc. Natl. Acad. Sci. USA, 74, 5463-5467.) with the modifications as described by Biggin et al. (Biggin, M.D. et al., (1983), Proc. Natl. Acad. Sci. USA, 80, 3963-3965), using .alpha.-.sup.35 S-dATP (2000 Ci/mmol) and Klenow enzyme (Amersham), ddNTP's (Pharmacia-PL Biochemicals) and dNTP's (Boehringer). The sequencing reaction products were separated on a denaturing polyacrylamide gel with a buffer gradient as described by Biggin et al. (Biggin, M.D. et al., (1983), Proc. Natl. Acad. Sci. USA, 80, 3963-3965). Purified, double-stranded plasmid DNA of pADC1 served as template in the sequence reaction, following the procedure described by Hattori and Sakaki (Hattori, M., and Sakaki, Y. (1986), Anal. Biochem. 152, 232-238). Deoxy-oligonucleotide primers were synthesized on a DNA synthesizer (Applied Biosystems 380A) using the phospho-amidit technique (Barone, A.D. et al., (1984), Nucleic Acid Research, 12, 4051-4061).
The DNA sequence when translated in all possible reading frames revealed a large open reading frame present in the center of insert between the HindIII- and the StuI sites (positions 550-2211, FIG. 1 and SEQ ID NO: 1). The open reading frame encodes a protein which consists of 554 amino acid residues followed by a TGA stop codon (FIG. 1). A ribosome binding site (RBS) is present directly upstream of this open reading frame (positions 534-538, FIG. 1 and SEQ ID NO: 1). Further upstream of the open reading frame a promoter is located. The sequences of its -35 (TTGTAA) and -10 (TAAAAT) (SEQ ID NO: 1 and FIG. 1, positions 458-463, and 481-486, respectively) correspond to those of constitutive promoters of gram-positive bacteria. Comparison of the primary structure of the gene product with protein sequences present in a protein data bank (EMBL Data Library), revealed sequence similarities with the .alpha.-acetolactate synthase enzymes from both E. coli (Squires et al. Nucleic Acid Res. 11:5299-5313 (1983)) and Saccharomyces cerevisiae (Falco et al. Nucleic Acid Res. 13: 4011-4027 (1985)). The GAP programme mentioned hereinbefore produced similarity percentages of 51% and 54%, respectively. Together with the NMR data described above (Example 1) it shows that the open reading frame is indeed the gene for .alpha.-ALS from L. diacetylactis.
EXAMPLE 3
Expression of .alpha.-ALS in Bacillus subtilis
To enhance .alpha.-ALS activity in B. subtilis, the 2.0 kbp HindIII-StuI fragment of pADCl, containing the complete .alpha.-acetolactate synthase gene, was transferred into the broad host range plasmid pGKV41, a derivative of the L. lactis plasmid pGKV410 (Van der Vossen J.M.B.M. PhD thesis, Rijksuniversiteit Groningen, 1988). Therefore, the said HindIII-StuI fragment was ligated in plasmid pGKV41 that was first digested with HindIII and SmaI to obtain plasmid pUR5400. The ligation mixture was used to transform B. subtilis DB105 protoplasts (Leenhouts, K., Kok J., and Venema, G., 1990. Appl. Environ. Microbiol. 56: 2726-2735) selecting for erythromycin-resistant colonies.
One of these transformants and DB105 control cells were tested by .sup.13 C NMR analysis. After cultivating for 18 hours in LB broth supplemented with or without (control cells) 5 .mu.g/ml erythromycin at 37.degree. C. the cells were harvested by centrifugation and washed with physiological salt solution. Subsequently the cells were taken up in phosphate buffer 0.002 mole/l at pH 7.0 and homogenized ultrasonically in the presence of acid-washed glass beads (<150 microns). The complete lysate was used to convert 36 .mu.mole 3-.sup.13 C-pyruvate which was contained in 1 ml reaction volume. The reaction mixture furthermore contained 100 .mu.l D.sub.2 O (for .sup.13 C-NMR purposes), thiamine pyrophosphate (0.25 .mu.mole) and MgSO.sub.4 (1.5 .mu.mole) in 0.06 mol/1 phosphate buffer at pH 6.5. The protein content of either lysate or extract was standardized at 0.9 mg protein/ml in the experiment.
In the lysates of DB105 cells containing pUR5400 pyruvate was converted very rapidly and almost quantitatively into .alpha.-acetolactate during the first two hours. In addition, lactate, acetate and at much lower rate acetoin were formed (FIG. 7). In lysates of the non-transformed DB105 host cells pyruvate was converted at a much slower rate yielding low, but detectable levels of lactate, acetate and .alpha.-acetolactate only (FIG. 8).
EXAMPLE 4
Expression of .alpha.-ALS in L. lactis subsp. lactis.
The complete .alpha.-acetolactate synthase gene was also cloned in the lactococcal plasmid vector pNZ123 (EPA 0 228 726 A1). From plasmid pADC1 the 2.0 kbp HindIII-StuI fragment was isolated, treated with Klenow enzyme to fill in the 3'-recessed ends, and subsequently ligated into pNZ123 which was cut with the restriction enzyme ScaI, resulting in pUR5401. The ligation mixture was used to transform E. coli 294 cells, selecting for transformants on LB plates containing 100 .mu.g/ml chloramphenicol. From the obtained transformants plasmid DNA was isolated, checked by restriction enzyme analysis, and subsequently used to electrotransform L. lactis. subsp. lactis (L. lactis) MG1363 cells (Leenhouts, K., Kok J., and Venema, G., 1990. Appl. Environ. Microbiol. 56: 2726-2735). From the obtained transformants one was tested by .sup.13 C-NMR analysis (together with MG1363 control cells).
Cells of L. lactis strain MG1363 with and without pUR5401 were cultivated in M17 broth which contained 1% (w/v) of glucose as carbohydrate. After growth cells were treated as described in the previous example (see above).
In lysates of the non-transformed MG1363 host cells pyruvate was converted at a rate of 0.118 .mu.mole/mg protein/min yielding about 10 mM .alpha.-acetolactate, and low levels of acetate and acetoin (FIG. 9). In lysates of MG1363(pUR5401) cells pyruvate was converted more rapidly, at a rate of 0.172 .mu.mole/mg protein/min yielding about 8 mM .alpha.-acetolactate (FIG. 10). However, acetoin is also formed at a higher rate than in non-transformed cells. The acetoin formation is concomittant with a decline of .alpha.-acetolactate levels and is most probably the result of .alpha.-ALD activity present in the lysate.
EXAMPLE 5
Expression of .alpha.-ALS in L. lactis subsp. lactis biovar diacetylactis SD803.
Expression of .alpha.-ALS was also studied in L. lactis subsp. lactis biovar diacetylactis (L. diacetylactis) strain SD803, a natural mutant defective in .alpha.-ALD activity (EP 0 247 646 B1). For this purpose the complete .alpha.-acetolactate synthase gene was transferred into the broad host range cloning vector pIL253 (Simon, D., and Chopin, A., Biochimie 70: 559-566 (1988)). The 4.1 kbp PstI-NruI fragment of pADC1 with the complete .alpha.-ALS gene was isolated, and ligated in plasmid pIL253 that was first digested with restriction enzymes PstI and SmaI. In this way plasmid pUR5402 was obtained. The ligation mixture was used to transform B. subtilis DB105 protoplasts (Leenhouts, K., Kok J., and Venema, G., 1990. Appl. Environ. Microbiol. 56: 2726-2735) selecting for erythromycin-resistant colonies. From the obtained transformant cells plasmid DNA was isolated, checked by restriction enzyme analysis, and a correct recombinant plasmid was subsequently used to electrotransform L. diacetylactis SD803 cells (Leenhouts, K., Kok J., and Venema, G., 1990. Appl. Environ. Microbiol. 56: 2726-2735). From the obtained transformants one was tested by .sup.13 C-NMR analysis (together with SD803 control cells).
Cells of L. diacetylactis strain SD803 with and without pUR5402 were cultivated in M17 broth which contained 1% (w/v) of glucose as carbohydrate. After growth cells were treated as described in example 3 (see above).
In lysates of the non-transformed SD803 cells pyruvate was converted almost completely into .alpha.-acetolactate, at a rate of 0.428 .mu.mole/mg protein/min. Only very low levels of acetoin could be detected, whereas formation of lactate and acetate was not observed at all (FIG. 11). In lysates of SD803(pUR5402) cells the conversion of pyruvate resulted in a quantitative formation of .alpha.-acetolactate, but at a much higher rate (3.49 .mu.mole/mg protein/min) than in the non-transformed SD803 cells (FIG. 12). Again, no lactate or acetate was formed and only very low levels of acetoin were detected.
EXAMPLE 6
Expression of .alpha.-acetolactate synthase by whole cells of Lactococcus lactis subsp. lactis biovar diacetylactis
This experiment was carried out to study the conversion of pyruvic acid by whole cells of Lactococcus lactis subsp. lactis biovar diacetylactis, which contain multiple copies of the .alpha.-acetolactate synthase gone. Therefore, strain SD803 was transformed with plasmids pUR5400 and pUR5402 (see Examples 3-5). The non-transformed 8D803 was used as the reference strain. The strains were cultivated overnight at 25.degree. C. in M17 broth which contained 1% (wt/vol) of lactose as carbohydrate and which was supplemented with 0.2% (wt/vol) of sodium citrate.
The rate of conversion of pyruvate and the type of reaction products formed by these strains was studied as described in Example 1. The final concentration of odium[3-.sup.13 C]pyruvate in the reaction liquid was 45.5 mmol/litre. 0.8 ml of the reaction mixture was transferred into a NMR tube which had a diameter of 0.5 cm, and the conversion of the pyruvate was monitored in the NMR apparatus at 30.degree. C.
For all three strains, the products formed were identical. However, it appeared that the rate at which the metabolites .alpha.-acetolactic acid and lactic acid were formed, was different. The rate of formation of .alpha.-acetolactic acid was significantly increased with the transformed strains, while the rate of formation of lactic acid was significantly decreased (sea Table 1). Moreover, after 90 min reaction time the conversion resulted in considerably higher concentrations of .alpha.-acetolactic acid and lower concentrations of lactic acid in the transformed strains as compared to the reference strain (see Table 2).
TABLE 1______________________________________ Rate of pyruvate utilisation and of metabolite formation,expressed as mmol utilized/formed per minute. The results werecalculated on the basis of a cell culture with an O.D..sub.610 of 3.45. .alpha.-AcetolacticStrain Pyruvate acid Lactic acid______________________________________SD803 -0.35 0.11 0.14SD803 (pUR5400) -0.33 0.15 0.08SD803 (pUR5402) -0.33 0.14 0.04______________________________________
TABLE 2______________________________________ Concentrations (mmol) of substrate and metabolites after 90minutes reaction time. .alpha.-Acetolactic LacticStrain Pyruvate acid Acetoin acid______________________________________SD803 20.24 6.33 0.09 11.93SD803 (pUR5400) 19.00 9.13 0.34 8.18SD803 (pUR5402) 20.63 8.93 0.37 5.49______________________________________
__________________________________________________________________________SEQUENCE LISTING(1) GENERAL INFORMATION:(iii) NUMBER OF SEQUENCES: 2(2) INFORMATION FOR SEQ ID NO:1:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 2538 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:CTGCAGC AGAACGTTATCTCGTGGATGCTTTAAATTTACCAGAATTACATGACGAAACAG60TCTTTTTGCTTGCTAATTTATACTTCAACGAAGAAGATTTTGAAGCTGTCATTAATCTTG120AAGAGCTTTTAGAAGATGAACATTTATTAGCTAAATGGCTTTTTGCAGGAGC ACATAAAG180CTTTGGAAAATGATTCTGAAGCGGCTGCTTTGTATGAAGAACTCATTCAAACCAATCTGT240CAGAGAATCCAGAGTTTTTAGAAGACTATATTGATTTTCTTAAAGAAATTGGTCAAATTT300CTAAAACAGAACCAATTATTGAACAATATT TGGAACTTGTTCCAGATGATGAAAATATGA360GAAATTTACTGACAGACTTAAAAAATAATTACTGACAAAGCTGTCAGTAATTATTTTTAT420TGTAAGCTAGAAAATTCAAAAACTTGCGTCAAAATAATTGTAAAAGGTTCTATTATCTGA480TAAAATG ATTGTGAAGTAATCCAAGAGATTATGAAATATGAATTAGAACAAATAGAGGTA540AAATAAAAAATGTCTGAGAAACAATTTGGGGCGAACTTGGTTGTCGATAGTTTGATTAAC600CATAAAGTGAAGTATGTATTTGGGATTCCAGGAGCAAAAATTGACCGGGTTT TTGATTTA660TTAGAAAATGAAGAAGGCCCTCAAATGGTCGTGACTCGTCATGAGCAAGGAGCTGCTTTC720ATGGCTCAAGCTGTCGGTCGTTTAACTGGCGAACCTGGTGTAGTAGTTGTTACGAGTGGG780CCTGGTGTATCAAACCTTGCGACTCCGCTT TTGACCGCGACATCAGAAGGTGATGCTATT840TTGGCTATCGGTGGACAAGTTAAACGAAGTGACCGTCTTAAACGTGCGCACCAATCAATG900GATAATGCTGGAATGATGCAATCAGCAACAAAATATTCAGCAGAAGTTCTTGACCCTAAT960ACACTTT CTGAATCAATTGCCAACGCTTATCGTATTGCAAAATCAGGACATCCAGGTGCA1020ACTTTCTTATCAATCCCCCAAGATGTAACGGATGCCGAAGTATCAATCAAAGCCATTCAA1080CCACTTTCAGACCCTAAAATGGGGAATGCCTCTATTGATGACATTAATTATT TAGCACAA1140GCAATTAAAAATGCTGTATTGCCAGTAATTTTGGTTGGAGCTGGTGCTTCAGATGCTAAA1200GTCGCTTCATCCTTGCGTAATCTATTGACTCATGTTAATATTCCTGTCGTTGAAACATTC1260CAAGGTGCAGGGGTTATTTCACATGATTTA GAACATACTTTTTATGGACGTATCGGTCTT1320TTCCGCAATCAACCAGGCGATATGCTTCTGAAACGTTCTGACCTTGTTATTGCTGTTGGT1380TATGACCCAATTGAATATGAAGCTCGTAACTGGAATGCAGAAATTGATAGTCGAATTATC1440GTTATTG ATAATGCCATTGCTGAAATTGATACTTACTACCAACCAGAGCGTGAATTAATT1500GGTGATATCGCAGCAACATTGGATAATCTTTTACCAGCTGTTCGTGGCTACAAAATTCCA1560AAAGGAACAAAAGATTATCTCGATGGCCTTCATGAAGTTGCTGAGCAACACG AATTTGAT1620ACTGAAAATACTGAAGAAGGTAGAATGCACCCTCTTGATTTGGTCAGCACTTTCCAAGAA1680ATCGTCAAGGATGATGAAACAGTAACCGTTGACGTAGGTTCACTCTACATTTGGATGGCA1740CGTCATTTCAAATCATACGAACCACGTCAT CTCCTCTTCTCAAACGGAATGCAAACACTC1800GGAGTTGCACTTCCTTGGGCAATTACAGCCGCATTGTTGCGCCCAGGTAAAAAAGTTTAT1860TCACACTCTGGTGATGGAGGCTTCCTTTTCACAGGGCAAGAATTGGAAACAGCTGTACGT1920TTGAATC TTCCAATCGTTCAAATTATCTGGAATGACGGCCATTATGATATGGTTAAATTC1980CAAGAAGAAATGAAATATGGTCGTTCAGCAGCCGTTGATTTTGGCTATGTTGATTACGTA2040AAATATGCTGAAGCAATGAGAGCAAAAGGTTACCGTGCACACAGCAAAGAAG AACTTGCT2100GAAATTCTCAAATCAATCCCAGATACTACTGGACCGGTGGTAATTGACGTTCCTTTGGAC2160TATTCTGATAACATTAAATTAGCAGAAAAATTATTGCCTGAAGAGTTTTATTGATTACAA2220TCAAGCAATTTGTGGCATAACAAAATAAAA GAAGAAGGCCTTGAACACCTAAGCGTTCAG2280GGCCTTTTTTTGTGAAATAAATTAGATGAAATTTACAATGAGTTTTGTGAAACTAGCTTC2340TAGTTTGTGAAAAATTGCCTATAATTGCCGAATAAAAATACCCATTTACCACTCCAAGAG2400GATGCTT CAAATTAGCTAAATACCCGTTTTAGAGGATGCGTAAAAACAACAAAAGAGGAT2460GAGTATAGAACGATAAAACTTTTTTATGATAGGTTGAGAGAATTGAATATAAAATATAAT2520AAGTAGAAGGCAGCAATT 2538(2) INFORMATION FOR SEQ ID NO:2:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 554 amino acids(B) TYPE: amino acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: peptide(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:MetSerGluLysGlnPheGlyAlaAsnLeuValValAsp SerLeuIle151015AsnHisLysValLysTyrValPheGlyIleProGlyAlaLysIleAsp2025 30ArgValPheAspLeuLeuGluAsnGluGluGlyProGlnMetValVal354045ThrArgHisGluGlnGlyAlaAlaPheMetAlaGlnAlaVal GlyArg505560LeuThrGlyGluProGlyValValValValThrSerGlyProGlyVal6570758 0SerAsnLeuAlaThrProLeuLeuThrAlaThrSerGluGlyAspAla859095IleLeuAlaIleGlyGlyGlnValLysArgSerAspArgLeu LysArg100105110AlaHisGlnSerMetAspAsnAlaGlyMetMetGlnSerAlaThrLys115120125TyrSerAlaGluValLeuAspProAsnThrLeuSerGluSerIleAla130135140AsnAlaTyrArgIleAlaLysSerGlyHisProGlyAlaThrPheLeu 145150155160SerIleProGlnAspValThrAspAlaGluValSerIleLysAlaIle1651701 75GlnProLeuSerAspProLysMetGlyAsnAlaSerIleAspAspIle180185190AsnTyrLeuAlaGlnAlaIleLysAsnAlaValLeuProValI leLeu195200205ValGlyAlaGlyAlaSerAspAlaLysValAlaSerSerLeuArgAsn210215220Leu LeuThrHisValAsnIleProValValGluThrPheGlnGlyAla225230235240GlyValIleSerHisAspLeuGluHisThrPheTyrGlyArgIleGl y245250255LeuPheArgAsnGlnProGlyAspMetLeuLeuLysArgSerAspLeu260265270ValIleAlaValGlyTyrAspProIleGluTyrGluAlaArgAsnTrp275280285AsnAlaGluIleAspSerArgIleIleValIleAspAsnAlaIleAla290295300GluIleAspThrTyrTyrGlnProGluArgGluLeuIleGlyAspIle305310315320 AlaAlaThrLeuAspAsnLeuLeuProAlaValArgGlyTyrLysIle325330335ProLysGlyThrLysAspTyrLeuAspGlyLeuHisGluValAla Glu340345350GlnHisGluPheAspThrGluAsnThrGluGluGlyArgMetHisPro355360365 LeuAspLeuValSerThrPheGlnGluIleValLysAspAspGluThr370375380ValThrValAspValGlySerLeuTyrIleTrpMetAlaArgHisPhe385 390395400LysSerTyrGluProArgHisLeuLeuPheSerAsnGlyMetGlnThr405410415 LeuGlyValAlaLeuProTrpAlaIleThrAlaAlaLeuLeuArgPro420425430GlyLysLysValTyrSerHisSerGlyAspGlyGlyPheLeuPheTh r435440445GlyGlnGluLeuGluThrAlaValArgLeuAsnLeuProIleValGln450455460IleIle TrpAsnAspGlyHisTyrAspMetValLysPheGlnGluGlu465470475480MetLysTyrGlyArgSerAlaAlaValAspPheGlyTyrValAspTyr 485490495ValLysTyrAlaGluAlaMetArgAlaLysGlyTyrArgAlaHisSer500505510 LysGluGluLeuAlaGluIleLeuLysSerIleProAspThrThrGly515520525ProValValIleAspValProLeuAspTyrSerAspAsnIleLysLeu 530535540AlaGluLysLeuLeuProGluGluPheTyr545550

Number	Date	Country
0204326	Jun 1986	EPX
247646	Dec 1987	EPX
356739	Mar 1990	EPX

Process for the preparation of .alpha.-acetolactic acid

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Abstract

Description

Claims

Priority Claims (1)

US Referenced Citations (1)

Foreign Referenced Citations (3)

Non-Patent Literature Citations (3)

Entry
Goelling, et al., "Cloning and Expression of an A-Acetolactate Decarboxylas Gene from Streptococcus lactis subsp. diacetylactis in Escherichia coli", Appl. Env. Microb., vol. 54, No. 7, Jul. 1988, pp. 1889-1891.
Falco et al Nucleic Acids Res. vol. 13 (11) pp. 4011-4027 issued 1985.
Glover Gene Cloning Chapman and Hall Ltd., New York, N.Y. 1984 Chapter 7 pp. 158-163.